| 1 |
Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: A 12-year follow-up study |
|
| | Nin, J.W., Jorsal, A., Ferreira, I., Schalkwijk, C.G., Prins, M.H., Parving, H.-H., Tarnow, L., (...), Stehouwer, C.D. | | | Diabetes Care. 2011; 34(2): 442-447 | | | [Pubmed] [Google Scholar] | | | 2 |
Polyneuropathy in type 1 and type 2 diabetes: do we need different examinations? |
|
| | Hans-Jürgen Gdynia, Albert C. Ludolph | | | Diabetes/Metabolism Research and Reviews. 2010; 26(2): 107-108 | | | [Pubmed] [Google Scholar] | | | 3 |
Reversibility of neuronal damage in diabetes: The search for a newer therapeutic paradigm |
|
| | Thomas, N. | | | Indian Journal of Medical Sciences. 2009; 63(4): 129-130 | | | [Pubmed] [Google Scholar] | |
|
